Dr. Robert M. Moldwin
Urogynecology (Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician)
- Medicare participating
At a glance
- Medical school
- University of Chicago, Pritzker School of Medicine (1984)
- Years since graduation
- 42
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 354
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1984Medical school: University of Chicago, Pritzker School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician primary
NY license 169519 -
Urology Physician
NY license 169519
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- North Shore University Hospital Manhasset, NY
Medical groups
- North Shore-Lij Medical PC (6,440 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 354
- Services billed
- 2,204
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Injection, heparin sodium, per 1000 units | 650 | 17 |
| Simple bladder irrigation and/or instillation | 335 | 68 |
| Established patient office or other outpatient visit, 30-39 minutes | 263 | 185 |
| Insertion of lower leg neurostimulator electrode | 177 | 27 |
| Established patient office or other outpatient visit, 20-29 minutes | 155 | 107 |
| Established patient office or other outpatient visit, 40-54 minutes | 115 | 92 |
| Ultrasound measurement of bladder capacity after voiding | 99 | 89 |
| Injection, garamycin, gentamicin, up to 80 mg | 68 | 19 |
| Diagnostic exam of bladder and urethra using an endoscope | 53 | 48 |
| New patient office or other outpatient visit, 60-74 minutes | 35 | 35 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in New Hyde PArk, NY | 78 |
| Alfuzosin Hcl Er (alfuzosin hcl) Other prescribers in New Hyde PArk, NY | 69 |
| Myrbetriq (mirabegron) Other prescribers in New Hyde PArk, NY | 51 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in New Hyde PArk, NY | 46 |
| Finasteride Other prescribers in New Hyde PArk, NY | 46 |
| Terazosin Hcl Other prescribers in New Hyde PArk, NY | 35 |
| Gemtesa (vibegron) Other prescribers in New Hyde PArk, NY | 35 |
| Estradiol Other prescribers in New Hyde PArk, NY | 34 |
| Dutasteride Other prescribers in New Hyde PArk, NY | 33 |
| Nitrofurantoin Mono-Macro (nitrofurantoin monohyd/m-cryst) Other prescribers in New Hyde PArk, NY | 28 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 5 payments worth $461 in total to this clinician.
| Medtronic, Inc. | $251 |
|---|---|
| Laborie Medical Technologies Corp. | $121 |
| AbbVie Inc. | $89.49 |
| Food and Beverage | $461 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $7,480 in research payments for these studies, mostly to the institutions running them.
- Study name not reported
Ironwood Pharmaceuticals, Inc
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.